Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Amy Ogilvie to Adrenergic beta-Antagonists

This is a "connection" page, showing publications Amy Ogilvie has written about Adrenergic beta-Antagonists.

 
Connection Strength
  
 
 
0.195
  
  1. Schultz JL, Ogilvie AC, Harshman LA, Nopoulos PC. ß-Blocker Use and Delayed Onset and Progression of Huntington Disease. JAMA Neurol. 2025 Jan 01; 82(1):85-92.
    View in: PubMed
    Score: 0.195
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)